Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
+3.13M
-
Total reported value, excl. options
-
$25.2M
-
Value change
-
+$4.99M
-
Number of buys
-
15
-
Number of sells
-
-19
-
Price
-
$1.58
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q4 2024
52 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q4 2024.
Apyx Medical Corp - Common Stock (APYX) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 35M outstanding shares and own 45.54% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (3.17M shares), Archon Capital Management LLC (3.14M shares), ROYCE & ASSOCIATES LP (2.62M shares), VANGUARD GROUP INC (1.48M shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), Silverberg Bernstein Capital Management LLC (571K shares), Taylor Frigon Capital Management LLC (546K shares), COMMONWEALTH EQUITY SERVICES, LLC (527K shares), BlackRock, Inc. (496K shares), and GEODE CAPITAL MANAGEMENT, LLC (353K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.